"A multi-center study of the device, conducted in Germany, demonstrated that patients who received a Latera implant experienced a reduction in nasal obstruction symptoms at 1-year post procedure, without a reported cosmetic downside.
“Nasal obstruction takes a significant toll on patient quality of life, but is often undertreated and underdiagnosed. If we don’t look for nasal valve collapse in these patients, we’re not addressing the entire problem. By providing an intuitive and effective way to support nasal Lateral cartilage, Latera has the potential to improve breathing for our patients,” Dr. Dean Toriumi of Chicago’s University of Illinois said in a press release.
“We have worked with physician leaders to find a solution to a major clinical need. The research and development behind the innovation is complex, but the technique is elegant and intuitive. Latera gives physicians a new option to support Lateral cartilage, enabling a more complete means for addressing their patients’ nasal obstruction symptoms,” CEO Duke Rohlen said in a prepared statement.
https://www.massdevice.com/spirox-wins-fda-nod-latera-nasal-implant/
http://www.spiroxmed.com/
No comments:
Post a Comment